Differential in vitro hepatic and intestinal metabolism of ifosfamide in the rat

Xenobiotica

Volumn 28, Issue 8, 1998, Pages 779-784

  Lu, Hong ^a   Chan, Kenneth K ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IFOSFAMIDE; XENOBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; HYDROXYLATION; IN VITRO STUDY; INTESTINE FLORA; LIVER METABOLISM; LIVER MICROSOME; METABOLITE; MICROFLORA; NONHUMAN; RAT; TOXICOKINETICS; XENOBIOTIC METABOLISM;

ANIMALIA;

EID: 0031686661     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982598239191     Document Type: Article

References (17)

1. CHANG, T. K. H., WEBER, G. F., CRESPI, C. L. and WAXMAN, D. J., 1993, Differential activation of cyclophosphamide and ifosfamide by cytochromes P-450 2B and 3A in human liver microsomes. Cancer Research, 53, 5629-5637.
2. FITZSIMMONS, M. E. and COLLINS, J. M., 1997, Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4-potential contribution to high first-pass metabolism. Drug Metabolism and Disposition, 25, 256-266.
3. GOREN, M. P., WRIGHT, R. K.,PRATT, C. B. and PELL, P. E., 1986, Dechloroethylation of ifosfamide and neurotoxicity. Lancet, ii, 1219-1220.
4. ILTT, K. F., TEE, L. B. G., REEVES, P. T. and MINCHIN, R. F., 1990, Metabolism of drugs and other xenobiotics in the gut lumen and wall. Pharmacology Therapeutics, 46, 67-93.
5. KRISHNA, D. R. and KLOTZ, U., 1994, Extrahepatic metabolism of drugs in humans. Clinical Pharmacokinetics, 26, 144-160.
6. KAIJSER, G. P., KORST, A., BEIJNEN, J. H., BULT, A. and UNDERBERG, W. J. M., 1993, The analysis of ifosfamide and its metabolite. Anticancer Research, 13, 1311-1324.
7. KAMINSKY, L. and FASCO, M. J., 1992, Small intestinal cytochromes P450. Critical Review of Toxicology, 21, 407-422.
8. NIEH, Y. C., 1994, Stereoselective disposition and bioavailability study of ifosfamide in the rat following oral administration. Master thesis, The Ohio State University.
9. RUZICKA, J. A. and RUENITZ, P. C., 1992, Cytochrome P-450-mediated N-dechloroethylation of cyclophosphamide and ifosfamide in the rat. Drug Metabolism and Disposition, 20, 770-772.
10. WAGNER, T., 1994, Ifosfamide clinical pharmacokinetics. Clinical Pharmacokinetics, 26, 439-456.
11. WAINER, I. W., DUCHARME, J., GRANVIL, C. P., TRUDEAN, M. and LEYLAND-JONES, B., 1994, Ifosfamide stereoselective dechloroethylation and neurotoxicity. Lancet, 343, 982-983.
12. WALKER, D., FLINOIS, J. P., MONKMAN, S. C., BELOC, C., BODDY, A. V., CHOLERTON, S., DALY, A. K., LIND, M. J., PEARSON, A. D. J., BEAUNE, P. H. and IDLE, J. R., 1994, Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamide. Biochemical Pharmacology, 47, 1157-1163.
13. WANG, J. H. and CHAN, K. K., 1995a, Identification of new metabolites of ifosfamide in rat urine using ion cluster technique. Journal of Mass Spectrometry, 30, 675-683.
14. WANG, J. H. and CHAN, K. K., 1995b, Analysis of ifosfamide, 4-hydroxyifosfamide, N2-dechloroethylifosfamide, N3-dechloroethylifosfamide, and iphosphamide mustard in plasma by gas chromatography-mass spectrometry. Journal of Chromatography, 674, 205-217.
15. WEBER, G. F. and WAXMAN, D. J., 1993, Activation of the anti-cancer drug ifosfamide by rat liver microsomal P450 enzymes. Biochemical Pharmacology, 45, 1685-1694.
16. YU, L. and WAXMAN, D. J., 1996, Role of cytochrome P450 in oxazaphosphorine metabolism, deactivation via N-dechloroethylation and activation via 4-hydroxylation catalyzed by distinct subsets of rat liver cytochrome P450. Drug Metabolism and Disposition, 24, 1254-1262.
17. ZHANG, Q. Y., WIKOFF, J., DUNBAR, D. and KAMINSKY, L., 1996, Characterization of rat small intestinal cytochrome P450 composition and inducibility. Drug Metabolism and Disposition, 24, 322-328.